Artemis Therapeutics Overview
- Founded
-
1997
- Status
-
Public
- Employees
-
1
- Stock Symbol
-
ATMS
- Investments
-
2
- Share Price
-
$0.30
- (As of Thursday Closing)
Artemis Therapeutics General Information
Description
Artemis Therapeutics Inc is exploring strategic alternatives. It is seeking a business combination candidate that would bring revenue and/or asset value to the company.
Contact Information
Website
www.artemis-therapeutics.com
Formerly Known As
Artemis Pharma
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
PINX
Primary Office
- 18 East 16th Street
- Suite 307
- New York, NY 10003
- United States
+1 (212) 000-0000
Artemis Therapeutics Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.30 | $0.70 | $0.27 - $5.00 | $78.4M | 112M | 3.04K | -$0.04 |
Artemis Therapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 135,590 | 5,054 | 2,153 | 364 |
| Revenue | 195 | 0 | 0 | 0 |
| EBITDA | (888) | (154) | (167) | (168) |
| Net Income | (869) | (167) | (121) | (121) |
| Total Assets | 356 | 7 | 11 | 22 |
| Total Debt | 356 | 196 | 110 | 103 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Artemis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Artemis Therapeutics Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Tomer Assis | Chief Financial Officer | ||
| Israel Alfassi | Director | ||
| Kacey Mor-Vu | Co-Founder | ||
| Nathalie Babazadeh | Co-Founder | ||
| Dana Wolf Ph.D | Chief Medical Officer |
Artemis Therapeutics Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 00000 | Self | Board Member | 000 0000 |
Artemis Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Artemis Therapeutics Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 (00000 | 30-Jun-2022 | 0000000000 | 000.00 | Personal Products | 00000 000 |
| Inksure Technologies | 23-Aug-2016 | Merger/Acquisition | IT Consulting and Outsourcing | 000000 00 |